Be the first to like.

Share

Mayes is billing his treatment as a would-be EpiPen for epilepsy, a way for patients to stop a seizure in its tracks when they feel one coming on. (He estimates there are about 200,000 such patients in the U.S. who can recognize early warning signs minutes or days before they have a seizure but don’t have any very fast-acting options to prevent it.)

He envisions another market, too — patients who’ve already had one seizure but want to prevent a second one, or those like his son Conner who can generally prevent seizures with daily medication but keep a backup on hand.

Mayes’s treatment, called Staccato alprazolam, combines two approved products: The generic type of benzodiazepine best known by the brand name Xanax. And to deliver it, an inhaler approved in 2012 to deliver an antipsychotic medication.

… Read More

Be the first to like.

Share
STAT

Tags: , , , , , , , , ,

Leave a Reply